Klyv Therapeutics has been accepted into the Nordic Mentor Network for Entrepreneurship (NOME). CEO Maria Vistnes represented the company as one of six finalists at the NOME Annual Meeting, where she was awarded this year’s pitch prize.
NOME is an elite mentoring programme for life science start-ups across the Nordic region, established in 2016 and supported by the Novo Nordisk Foundation. It pairs selected companies with experienced mentors — investors, entrepreneurs, and senior life science executives — who provide guidance on strategy and on building companies with international reach.
For Klyv, acceptance into the programme means access to this network of mentors and to the wider Nordic life science community as the company continues to develop its anti-fibrotic approach to cardiac fibrosis and heart failure. It is a useful source of experience and connections at an early and formative stage.